Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Michele Fox

Concepts (268)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hematopoietic Stem Cell Mobilization
11
2018
56
1.480
 Why?
Multiple Myeloma
26
2024
2949
1.400
 Why?
Hematopoietic Stem Cell Transplantation
13
2023
555
1.280
 Why?
Hematopoietic Stem Cells
8
2018
182
1.250
 Why?
Blood Platelets
5
2017
252
0.810
 Why?
Antigens, CD34
9
2018
65
0.750
 Why?
Melphalan
4
2016
173
0.570
 Why?
Leukapheresis
3
2018
15
0.560
 Why?
Bone Marrow Transplantation
4
2016
112
0.550
 Why?
Blood Component Removal
4
2018
10
0.540
 Why?
Purpura, Thrombotic Thrombocytopenic
2
2018
15
0.530
 Why?
Antineoplastic Combined Chemotherapy Protocols
7
2024
1003
0.530
 Why?
Plasma Exchange
3
2015
23
0.500
 Why?
Fetal Blood
3
2023
70
0.450
 Why?
Cell Separation
2
2013
89
0.410
 Why?
Pregnant Women
1
2023
74
0.390
 Why?
Killer Cells, Natural
2
2015
106
0.380
 Why?
Cell Proliferation
5
2018
989
0.360
 Why?
Immunotherapy, Adoptive
2
2015
162
0.350
 Why?
Transplantation, Autologous
8
2013
464
0.350
 Why?
Myelodysplastic Syndromes
2
2013
79
0.340
 Why?
Granulocyte Colony-Stimulating Factor
4
2012
60
0.340
 Why?
Humans
43
2024
50389
0.340
 Why?
Blood Specimen Collection
1
2019
36
0.320
 Why?
Thalidomide
4
2016
374
0.320
 Why?
Blood Transfusion
2
2017
127
0.320
 Why?
Blood Volume
1
2019
69
0.310
 Why?
Education, Distance
1
2019
41
0.310
 Why?
Aged
21
2017
9590
0.310
 Why?
Adult
22
2019
13568
0.310
 Why?
Clinical Laboratory Techniques
1
2018
30
0.300
 Why?
Obstetrics
1
2019
88
0.290
 Why?
Leukocytes, Mononuclear
1
2018
113
0.290
 Why?
Cyclooxygenase Inhibitors
1
2017
38
0.290
 Why?
Blood Grouping and Crossmatching
1
2017
5
0.280
 Why?
Blood Coagulation
1
2017
58
0.280
 Why?
Chromosome Aberrations
3
2016
295
0.280
 Why?
Middle Aged
21
2018
12460
0.280
 Why?
Flow Cytometry
2
2016
475
0.270
 Why?
Antibodies
1
2016
151
0.260
 Why?
Aspirin
1
2017
111
0.260
 Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2017
122
0.260
 Why?
Erythrocyte Transfusion
2
2015
50
0.260
 Why?
Platelet Aggregation Inhibitors
1
2017
174
0.260
 Why?
Female
22
2023
26981
0.240
 Why?
Hemoglobins, Abnormal
1
2015
4
0.240
 Why?
Heparin
1
2015
91
0.240
 Why?
Thrombocytopenia
1
2015
84
0.240
 Why?
Stem Cell Transplantation
2
2013
179
0.240
 Why?
Factor VIII
1
2014
23
0.230
 Why?
ADAM Proteins
1
2014
20
0.230
 Why?
Leukocytes
2
2011
69
0.230
 Why?
Anemia, Sickle Cell
1
2015
94
0.220
 Why?
Male
21
2019
25718
0.220
 Why?
Follow-Up Studies
8
2024
2219
0.220
 Why?
Internship and Residency
1
2019
444
0.220
 Why?
Antiretroviral Therapy, Highly Active
1
2013
33
0.210
 Why?
Leukemia
1
2013
64
0.210
 Why?
Afibrinogenemia
1
2012
5
0.200
 Why?
Neoplasm Recurrence, Local
2
2015
634
0.200
 Why?
Graft Survival
4
2011
153
0.200
 Why?
Prognosis
6
2018
1979
0.190
 Why?
Aldehyde Dehydrogenase
1
2011
25
0.190
 Why?
Transplantation Conditioning
3
2003
82
0.190
 Why?
Boronic Acids
2
2013
182
0.180
 Why?
Pyrazines
2
2013
187
0.180
 Why?
Plateletpheresis
1
2010
7
0.180
 Why?
Blood Preservation
1
2010
26
0.180
 Why?
Transplantation, Homologous
5
2016
140
0.180
 Why?
Retrospective Studies
8
2018
6223
0.180
 Why?
Cryopreservation
1
2010
31
0.180
 Why?
Blood Proteins
1
2010
77
0.180
 Why?
Anaphylaxis
1
2010
70
0.170
 Why?
Chromosomes, Human, Pair 1
2
2007
92
0.160
 Why?
Cell Survival
5
2011
590
0.160
 Why?
Graft vs Host Disease
5
2003
73
0.160
 Why?
HIV Infections
1
2013
355
0.160
 Why?
Receptors, KIR
1
2008
13
0.160
 Why?
Gene Expression Regulation, Neoplastic
2
2016
830
0.150
 Why?
Myeloablative Agonists
1
2007
30
0.140
 Why?
Cell Movement
2
2006
246
0.140
 Why?
Immunosuppressive Agents
2
2014
223
0.140
 Why?
Treatment Outcome
11
2013
5230
0.140
 Why?
Dexamethasone
3
2024
437
0.140
 Why?
Risk Factors
7
2015
3692
0.130
 Why?
Models, Genetic
1
2006
174
0.130
 Why?
Osteogenesis
2
2006
353
0.130
 Why?
Models, Statistical
1
2007
226
0.130
 Why?
Young Adult
4
2019
4064
0.130
 Why?
Combined Modality Therapy
4
2014
641
0.120
 Why?
Gene Expression Profiling
2
2007
1029
0.120
 Why?
Cytokines
2
2006
606
0.120
 Why?
Platelet Count
3
2017
74
0.120
 Why?
Macrophages
1
2018
363
0.120
 Why?
Incidence
3
2017
1017
0.120
 Why?
Enzyme-Linked Immunosorbent Assay
2
2015
234
0.120
 Why?
Antineoplastic Agents
3
2012
1178
0.110
 Why?
Time Factors
1
2010
2934
0.110
 Why?
Pregnancy
2
2023
2610
0.110
 Why?
Cytotoxicity Tests, Immunologic
2
2016
27
0.110
 Why?
Disease-Free Survival
3
2016
450
0.110
 Why?
Blood Banks
1
2023
17
0.110
 Why?
Bone Marrow Cells
1
2004
190
0.110
 Why?
Metaphase
2
2016
45
0.100
 Why?
Bone Diseases
1
2004
97
0.100
 Why?
Osteoblasts
1
2006
453
0.100
 Why?
Cell Count
3
2011
147
0.100
 Why?
Cyclosporine
1
2003
65
0.100
 Why?
Tacrolimus
1
2003
54
0.100
 Why?
Blood Group Incompatibility
1
2002
5
0.100
 Why?
ABO Blood-Group System
1
2002
15
0.100
 Why?
Universities
1
2023
170
0.100
 Why?
Kaplan-Meier Estimate
3
2007
466
0.100
 Why?
Coculture Techniques
3
2018
143
0.100
 Why?
Osteoclasts
1
2004
424
0.090
 Why?
T-Lymphocyte Subsets
1
2001
38
0.090
 Why?
Models, Biological
1
2004
723
0.090
 Why?
T-Lymphocytes, Cytotoxic
1
2010
64
0.090
 Why?
Heart Failure
1
2006
526
0.090
 Why?
Prospective Studies
4
2016
2414
0.080
 Why?
Lung Diseases
1
2001
98
0.080
 Why?
Thrombosis
1
2003
249
0.080
 Why?
Cancer Vaccines
1
2010
78
0.080
 Why?
Dendritic Cells
1
2010
133
0.080
 Why?
Erythroid Precursor Cells
1
2019
15
0.080
 Why?
Birth Weight
1
2019
121
0.080
 Why?
Hematocrit
1
2018
45
0.080
 Why?
Medical Waste
1
2017
2
0.070
 Why?
Cell Aggregation
1
2017
6
0.070
 Why?
Antineoplastic Agents, Alkylating
2
2008
74
0.070
 Why?
Lymphoma
1
2018
65
0.070
 Why?
Arkansas
2
2017
1991
0.070
 Why?
Program Evaluation
1
2019
349
0.070
 Why?
Lymphoma, Follicular
1
2017
27
0.070
 Why?
Histocompatibility Antigens Class I
1
2017
44
0.070
 Why?
Logistic Models
2
2017
900
0.070
 Why?
Adolescent
3
2015
6475
0.070
 Why?
Neoplasms
1
2007
1237
0.070
 Why?
Lung
1
2001
512
0.070
 Why?
Risk
1
2017
316
0.070
 Why?
Fibrosis
1
2017
179
0.070
 Why?
Dose-Response Relationship, Drug
3
2008
1356
0.070
 Why?
Lymphoma, Large B-Cell, Diffuse
1
2017
104
0.060
 Why?
Curriculum
1
2019
398
0.060
 Why?
Recurrence
2
2008
664
0.060
 Why?
Hemorrhage
1
2017
197
0.060
 Why?
Hemoglobin J
1
2015
3
0.060
 Why?
Hemoglobin, Sickle
1
2015
6
0.060
 Why?
Hemoglobin C
1
2015
6
0.060
 Why?
Blood Donors
1
2015
31
0.060
 Why?
Diagnosis, Differential
1
2018
1042
0.060
 Why?
Neoplasm Proteins
1
2016
321
0.060
 Why?
Reproducibility of Results
1
2017
1201
0.060
 Why?
Autoantibodies
1
2014
114
0.060
 Why?
Age Factors
3
2005
1104
0.060
 Why?
Blotting, Western
1
2015
587
0.050
 Why?
CD4 Lymphocyte Count
1
2013
32
0.050
 Why?
Viral Load
1
2013
76
0.050
 Why?
Transplantation Chimera
3
2003
15
0.050
 Why?
Acute Disease
1
2013
370
0.050
 Why?
Benzylamines
1
2012
15
0.050
 Why?
Receptors, CXCR4
1
2012
27
0.050
 Why?
Immunohistochemistry
1
2015
975
0.050
 Why?
Granulocyte-Macrophage Colony-Stimulating Factor
1
2012
54
0.050
 Why?
Heterocyclic Compounds
1
2012
29
0.050
 Why?
Infant, Newborn
1
2019
2780
0.050
 Why?
Clinical Protocols
1
2012
109
0.050
 Why?
Immune Tolerance
1
2011
84
0.050
 Why?
Dimethyl Sulfoxide
1
2010
12
0.050
 Why?
Isotonic Solutions
1
2010
18
0.040
 Why?
Platelet Transfusion
1
2010
28
0.040
 Why?
P-Selectin
1
2010
32
0.040
 Why?
Algorithms
2
2005
618
0.040
 Why?
Sodium Chloride
1
2010
58
0.040
 Why?
Platelet Aggregation
1
2010
71
0.040
 Why?
Platelet Activation
1
2010
47
0.040
 Why?
Multivariate Analysis
2
2007
583
0.040
 Why?
Hypersensitivity
1
2010
75
0.040
 Why?
Feasibility Studies
1
2011
386
0.040
 Why?
Haplotypes
1
2008
82
0.040
 Why?
Nitric Oxide Synthase Type II
1
2018
65
0.040
 Why?
Ligands
1
2008
203
0.040
 Why?
Arginase
1
2018
37
0.040
 Why?
Polyethylene Glycols
1
2008
86
0.040
 Why?
Hemoglobins
1
2008
106
0.040
 Why?
Age Distribution
1
2007
170
0.040
 Why?
Cytogenetic Analysis
1
2007
80
0.030
 Why?
Tissue Donors
2
2003
112
0.030
 Why?
Recombinant Proteins
1
2008
482
0.030
 Why?
Antineoplastic Agents, Hormonal
1
2007
49
0.030
 Why?
Multigene Family
1
2006
56
0.030
 Why?
Mice
2
2018
5688
0.030
 Why?
Chromosome Deletion
1
2007
140
0.030
 Why?
Chromosome Mapping
1
2006
158
0.030
 Why?
In Situ Hybridization, Fluorescence
1
2007
256
0.030
 Why?
Angiogenesis Inhibitors
1
2007
182
0.030
 Why?
Leukemia, Myeloid, Acute
1
2007
180
0.030
 Why?
Cell Line
1
2008
1010
0.030
 Why?
Cell Communication
1
2006
69
0.030
 Why?
Interleukin-10
1
2006
84
0.030
 Why?
Neoplasms, Experimental
1
2006
111
0.030
 Why?
Stroke Volume
1
2006
143
0.030
 Why?
Predictive Value of Tests
1
2007
934
0.030
 Why?
Ventricular Dysfunction, Left
1
2006
104
0.030
 Why?
Myocardial Ischemia
1
2006
118
0.030
 Why?
Databases, Factual
1
2007
667
0.030
 Why?
Mice, Transgenic
1
2006
543
0.030
 Why?
Receptor Activator of Nuclear Factor-kappa B
1
2004
30
0.030
 Why?
Bromodeoxyuridine
1
2004
19
0.030
 Why?
Annexin A5
1
2004
13
0.030
 Why?
Culture Media, Conditioned
1
2004
48
0.030
 Why?
Phagocytosis
1
2004
49
0.030
 Why?
Survival Rate
1
2006
915
0.030
 Why?
Tumor Necrosis Factor-alpha
1
2006
388
0.030
 Why?
Aged, 80 and over
2
2006
3180
0.030
 Why?
Cell Division
1
2004
294
0.030
 Why?
Chronic Disease
1
2006
570
0.030
 Why?
Plasmapheresis
1
2003
11
0.030
 Why?
RANK Ligand
1
2004
184
0.030
 Why?
Membrane Glycoproteins
1
2004
244
0.030
 Why?
Interleukin-6
1
2004
266
0.030
 Why?
Salvage Therapy
2
2003
136
0.030
 Why?
Cohort Studies
1
2006
1426
0.030
 Why?
Severity of Illness Index
1
2006
963
0.030
 Why?
Child
1
2015
6877
0.030
 Why?
NF-kappa B
1
2004
315
0.030
 Why?
Carrier Proteins
1
2004
302
0.020
 Why?
Red-Cell Aplasia, Pure
1
2002
7
0.020
 Why?
Animals
2
2018
13173
0.020
 Why?
Antigens, CD
1
2003
216
0.020
 Why?
Survival Analysis
2
2003
671
0.020
 Why?
Gene Rearrangement, T-Lymphocyte
1
2001
2
0.020
 Why?
Cell Differentiation
1
2004
651
0.020
 Why?
Lymphocyte Count
1
2001
20
0.020
 Why?
Bronchoalveolar Lavage Fluid
1
2001
40
0.020
 Why?
Clone Cells
1
2001
78
0.020
 Why?
Graft Rejection
1
2002
168
0.020
 Why?
Disease Models, Animal
1
2006
1419
0.020
 Why?
Immunoglobulin Idiotypes
1
2010
5
0.020
 Why?
CD40 Ligand
1
2010
14
0.020
 Why?
Hypersensitivity, Delayed
1
2010
19
0.020
 Why?
Interleukin-4
1
2010
44
0.020
 Why?
Immunity, Cellular
1
2010
69
0.020
 Why?
Adjuvants, Immunologic
1
2010
51
0.020
 Why?
CD8-Positive T-Lymphocytes
1
2001
123
0.020
 Why?
Magnetic Resonance Imaging
1
2007
1534
0.020
 Why?
Interferon-gamma
1
2010
176
0.020
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2001
578
0.020
 Why?
Transcription, Genetic
1
2001
371
0.020
 Why?
CD4-Positive T-Lymphocytes
1
2001
157
0.020
 Why?
B-Lymphocytes
1
2010
175
0.020
 Why?
Vaccination
1
2010
275
0.020
 Why?
Stem Cell Factor
1
2003
7
0.010
 Why?
Confidence Intervals
1
2003
154
0.010
 Why?
Probability
1
2003
165
0.010
 Why?
Lymphocyte Transfusion
1
2003
10
0.010
 Why?
Leukocyte Count
1
2003
72
0.010
 Why?
Infusions, Intravenous
1
2003
213
0.010
 Why?
Cyclophosphamide
1
2003
164
0.010
 Why?
Drug Administration Schedule
1
2003
369
0.010
 Why?
Remission Induction
1
2003
206
0.010
 Why?
Administration, Oral
1
2003
432
0.010
 Why?
Doxorubicin
1
2003
234
0.010
 Why?
Neutrophils
1
2003
148
0.010
 Why?
Cisplatin
1
2003
275
0.010
 Why?
Neoplasm Staging
1
2003
750
0.010
 Why?
Drug Resistance, Neoplasm
1
2003
318
0.010
 Why?
Disease Progression
1
2003
823
0.010
 Why?
Fox's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (268) concept(s)
_
Co-Authors Expand Description
See all (26) people
_
Similar People Expand Description
See all (32) people
_
Same Department Expand Description
Search Department